Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
Condition:   ADHD Interventions:   Drug: NRCT-101-SR;   Drug: Placebo Sponsor:   Neurocentria, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials

Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
Condition:   ADHD Interventions:   Drug: NRCT-101-SR;   Drug: Placebo Sponsor:   Neurocentria, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials